Technical

Technical — The Price Picture

Greggs trades at £16.43, just above a flattening 200-day average (+1.5%) but 27% below its 52-week high. The near-term tape has turned constructive — RSI 61, MACD histogram positive, price pushing through the 20-day — yet the 3-year chart still shows a classic distribution pattern after the January 2025 volume-driven gap down. Momentum says "relief rally"; trend says "prove it."

Price snapshot

The critical chart — 10 years of price with 50/200 SMA

Price is above the 200-day SMA (£16.43 vs £16.19, +1.5%) for the first sustained stretch since the November 2024 death cross, but the 50-day (£15.91) is still below the 200-day and flattening — the classic bottoming pattern where trend has to catch up to momentum, not the other way around. The 10-year view is a sideways regime: 2016–2019 uptrend, 2020 COVID crash, 2021 blow-off top to £34, then a two-year distribution back to 2018 levels.

Relative strength — GRG vs UK market

Over the last three years Greggs has lagged the UK market by 87 index points — GRG at 61 versus EWU at 149. The gap widened sharply in January 2025 and has continued to widen through 2026 despite the recent bounce. No UK sector ETF was available for a sector-level comparison, so this is a broad-market read only. On a relative basis this is not a recovery yet; it is a stock that has fallen further than the market and started to find a floor.

Momentum — RSI and MACD, last 18 months

RSI sits at 61 — firmly in bullish territory but not yet overbought, and the slope has been rising since February. MACD histogram has flipped positive and the MACD line crossed above signal in early April, confirming the RSI read. Near-term (1–3 month) momentum is clearly constructive; the question is whether this is a lower-high attempt or the start of a real reclaim.

Volume and conviction — 12 months

The three biggest volume spikes in the last 18 months are all single-day drawdowns of 6–16% on 5–12x average volume. Recent trend is rising on shrinking volume (the 50-day average sits near the daily prints), while selling pressure has been punctuated by panic days — the opposite of what a healthy bottom looks like. Conviction is weak: the bounce is real but thin.

Volatility regime — 5-year realized vol

Realized 30-day vol sits at 22.8%, squarely in the "normal" band (17.7%–39.0% over 10-year history) and well below the January 2025 spike near 50%. The market is no longer pricing crisis into Greggs, but it is not pricing calm either — vol is elevated versus the late-2024 lull. Call it "watchful."

Technical scorecard

Stance — Neutral-to-bearish, 3–6 month horizon

Net score: −2 of 6. The near-term momentum read is genuinely constructive — RSI and MACD agree, price is back above the 200-day, the bleed has stopped. But the weight of evidence on the longer tape is negative: death cross still unresolved, four of the last five high-volume days were panic sells, three years of relative underperformance against a UK market that is up nearly 50%, and a price sitting in the bottom third of its 52-week range with heavy overhead supply between here and the £22 highs. This looks like a counter-trend rally inside a broader stall, not the start of a new leg.

Stance: neutral-to-bearish. Two levels that would change the view:

• Bullish confirmation: a weekly close above £17.50 — that reclaims the 100-day SMA (£16.28), breaks the sequence of lower highs since January 2025, and lets the 50-day curl up through the 200-day for a fresh golden cross. Above £17.50 the technical case flips to long, targeting £20–22.
• Bearish confirmation: a daily close below £15.00 — that breaks the February–April base, invalidates the RSI/MACD setup, and opens the path to re-test the July 2025 low at £14.07. Below £14 the 2022 lows near £19 are gone and the next real support is the pandemic-era £14 floor.

Until one of those levels prints, this is a show-me tape — carry small.